Related references
Note: Only part of the references are listed.Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells
Jen-Chung Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?
Caitrin Crudden et al.
GROWTH HORMONE & IGF RESEARCH (2015)
PI3K/AKT signaling pathway and cancer: an updated review
Miriam Martini et al.
ANNALS OF MEDICINE (2014)
PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
HaiXia Li et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2014)
Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Claudia Fumarola et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts
Sonia Chamorro et al.
MABS (2014)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Peter E. Czabotar et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9
Miguel Parra et al.
VIROLOGY (2014)
CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis
Pranav Gupta et al.
ONCOTARGET (2014)
Updates and Controversies in the Rapidly Evolving Field of Lung Cancer Screening, Early Detection, and Chemoprevention
Hasmeena Kathuria et al.
CANCERS (2014)
Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
Haiying Cheng et al.
LUNG CANCER MANAGEMENT (2014)
Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects
Marc Dufour et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Characterization of the CCR3 and CCR9 genes in miiuy croaker and different selection pressures imposed on different domains between mammals and teleosts
Zhihuang Zhu et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2013)
Regional imbalanced activation of the calcineurin/BAD apoptotic pathway and the PI3K/Akt survival pathway after myocardial infarction
Tieluo Li et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells
Eileen L. Heinrich et al.
CANCER MICROENVIRONMENT (2013)
Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor
Andreas Schlitzer et al.
BLOOD (2012)
Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
Naoko Kuzumaki et al.
PLOS ONE (2012)
Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab
Neil E. Bhola et al.
CLINICAL CANCER RESEARCH (2011)
CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion
Crystal Johnson-Holiday et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells
Dong-Jun Peng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide
Praveen K. Sharma et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion
Erica L. Johnson et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function
Jon Nilsen et al.
BMC NEUROSCIENCE (2006)
Premature expression of chemokine receptor CCR9 impairs T cell development
S Uehara et al.
JOURNAL OF IMMUNOLOGY (2006)
The activation of Akt/PKB signaling pathway and cell survival
G Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Blocking of c-FLEPL-independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction
BS Youn et al.
BLOOD (2001)
Share Paper
